Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-07-31 to 2025-08-11
Current total value of award: $927.23
Description: 8511542630!TYPHOID VI POLYSACC